Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?
(2018) In Life Sciences Intellectual Property Review (LSIPR)- Abstract
- As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/156e74ea-00a1-49f3-8259-b9d9c244c16a
- author
- Wested, Jakob ; Minssen, Timo LU and Van Zimmeren, Esther
- publishing date
- 2018-07-13
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Medical law, Medicinsk rätt
- in
- Life Sciences Intellectual Property Review (LSIPR)
- issue
- 13/7 2018
- language
- English
- LU publication?
- no
- id
- 156e74ea-00a1-49f3-8259-b9d9c244c16a
- date added to LUP
- 2020-12-16 14:17:59
- date last changed
- 2020-12-17 16:57:35
@article{156e74ea-00a1-49f3-8259-b9d9c244c16a, abstract = {{As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.}}, author = {{Wested, Jakob and Minssen, Timo and Van Zimmeren, Esther}}, keywords = {{Medical law; Medicinsk rätt}}, language = {{eng}}, month = {{07}}, number = {{13/7 2018}}, series = {{Life Sciences Intellectual Property Review (LSIPR)}}, title = {{Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?}}, year = {{2018}}, }